No scientist named “Jordan Grant” and no Dutch scientific journal called “Next Level” can be located anywhere, and the sole cited source isn’t an academic publication at all.
What actually happened to gene theory, CRISPR, and GMO safety is considerably less dramatic than a collapse: decades of independently replicated research, a Nobel-adjacent sequencing project, and a Supreme Court ruling that already blocks the exact “patented human genome” scenario this narrative treats as inevitable.
“The Collapse of Gene Theory” Never Happened
Genes have been directly isolated, sequenced, and mapped for decades. The Human Genome Project, completed in 2003, sequenced the entire human genome and identified roughly 20,000 protein-coding genes, work independently replicated and extended by thousands of research teams worldwide since. It’s true that molecular biology has revealed genes are more dynamic and context-dependent than early 20th-century “blueprint” metaphors suggested, epigenetics and gene regulation are actively studied fields in their own right, but that nuance refines the picture, it doesn’t equate to genes being unreal or unverified, a claim with no support anywhere in biology.
CRISPR Isn’t Crude, It’s FDA-Approved
CRISPR gene editing does carry documented off-target effects, and researchers actively study and work to minimize them, an ongoing safety-improvement effort, not evidence the tool is fundamentally unpredictable. CRISPR-based therapies have already cleared regulatory approval: Casgevy, approved by the FDA in December 2023 for sickle cell disease and beta thalassemia, followed extensive clinical trials demonstrating measurable precision and therapeutic benefit.
Gene Patenting Is a Real Debate, and It Already Has Real Limits
This part deserves fair treatment, since it’s a legitimate policy debate underneath the fabricated citation. Gene and seed patenting raises significant, actively debated ethical and economic questions, and legal scholars and bioethicists have published extensively on the tension between patent law’s purpose, incentivizing research investment, and legitimate concerns about corporate control over agricultural seed supplies. What’s worth knowing directly is that this debate has already produced a significant legal limit: the U.S. Supreme Court’s 2013 decision in Association for Molecular Pathology v. Myriad Genetics ruled that naturally occurring human genes cannot be patented, a ruling that already blocks the “patented human genome” scenario treated here as an unstoppable certainty.
GMOs Aren’t “Radiation and Chemical Roulette”
Modern genetically modified organisms are overwhelmingly created through targeted gene insertion or precise editing techniques, not primarily radiation or chemical mutagenesis, an older, largely separate breeding technique called mutation breeding that predates modern GMO technology and has itself been used safely for decades. The World Health Organization, the National Academies of Sciences, and hundreds of independent studies conducted over more than 25 years have consistently found approved GMO foods safe for human consumption, an extensively replicated scientific consensus, not a manufactured distraction.
Dolly and He Jiankui: Real Events, Backwards Framing
Dolly the sheep was a genuine cloned mammal, produced by researchers at the Roslin Institute in 1996, extensively documented and peer-reviewed at the time. The 2018 case of gene-edited twins in China was real and genuinely controversial, but for the opposite reason usually implied: scientists worldwide publicly condemned the researcher responsible, He Jiankui, for conducting unauthorized, ethically unapproved human embryo editing, and he was subsequently sentenced to prison in China for illegal medical practice. That’s a scandal precisely because it violated established research ethics, the system working as intended, not evidence of a coordinated cover story.
What Patented Seed Restrictions Actually Cover
This issue is more specific, and more legally narrow, than blanket “enslavement” framing suggests. Patented seed restrictions apply specifically to patented varieties farmers voluntarily purchase under licensing agreements, contracts farmers can decline. Non-patented, traditional, and heirloom seed varieties remain entirely free to save, replant, and share, and many farmers worldwide continue growing exclusively non-patented crops. That’s the actual line: a specific contractual restriction on certain purchased products, not a universal prohibition on seed-saving.
What Epigenetics Actually Found
Epigenetics studies how gene expression switches on or off through chemical modifications to DNA and its associated proteins, without altering the underlying genetic sequence itself, an extensively published field with thousands of peer-reviewed studies since its modern emergence in the early 2000s. This research has refined understanding of how genes interact with environment and development, but it builds on and extends confirmed genetic mechanisms rather than overturning them. Geneticists studying epigenetics routinely use the same sequencing and identification techniques dismissed elsewhere as unverified, precisely because those techniques remain foundational to the field’s own published methodology.
The Debate Worth Having
Corporate consolidation in agriculture, seed patent scope, and equitable access to genetic technology are legitimate concerns deserving serious, informed public debate, grounded in accurate science and accurate law. How patent law should balance innovation incentives against food sovereignty and genetic commons is a real, unresolved question worth engaging with directly, precisely because it’s unresolved, not because gene theory itself is in any doubt.
The Resonance Archives
